148 related articles for article (PubMed ID: 21296634)
1. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
Bayram S; Akkız H; Bekar A; Akgöllü E
Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
[TBL] [Abstract][Full Text] [Related]
2. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
[TBL] [Abstract][Full Text] [Related]
3. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
[TBL] [Abstract][Full Text] [Related]
4. Lack of an association of programmed cell death-1 PD1.3 polymorphism with risk of hepatocellular carcinoma susceptibility in Turkish population: a case-control study.
Bayram S; Akkız H; Ülger Y; Bekar A; Akgöllü E; Yıldırım S
Gene; 2012 Dec; 511(2):308-13. PubMed ID: 23041554
[TBL] [Abstract][Full Text] [Related]
5. RASSF1A Ala133Ser polymorphism is associated with increased susceptibility to hepatocellular carcinoma in a Turkish population.
Bayram S
Gene; 2012 May; 498(2):264-9. PubMed ID: 22394463
[TBL] [Abstract][Full Text] [Related]
6. Survivin promoter polymorphism and cervical carcinogenesis.
Borbély AA; Murvai M; Szarka K; Kónya J; Gergely L; Hernádi Z; Veress G
J Clin Pathol; 2007 Mar; 60(3):303-6. PubMed ID: 16714396
[TBL] [Abstract][Full Text] [Related]
7. Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India.
Upadhyay R; Khurana R; Kumar S; Ghoshal UC; Mittal B
Ann Surg Oncol; 2011 Mar; 18(3):880-7. PubMed ID: 20957442
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population.
Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S
Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161
[TBL] [Abstract][Full Text] [Related]
9. Survivin gene promoter polymorphism -31G/C as a risk factor for keratocystic odontogenic tumor development.
Andric M; Nikolic N; Boskovic M; Milicic B; Skodric S; Basta Jovanovic G; Milasin J
Eur J Oral Sci; 2012 Feb; 120(1):9-13. PubMed ID: 22288915
[TBL] [Abstract][Full Text] [Related]
10. Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma.
Cheng ZJ; Hu LH; Huang SJ
Ai Zheng; 2008 Mar; 27(3):258-63. PubMed ID: 18334114
[TBL] [Abstract][Full Text] [Related]
11. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E
Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Üsküdar O
Asian Pac J Cancer Prev; 2011; 12(11):3107-12. PubMed ID: 22393998
[TBL] [Abstract][Full Text] [Related]
13. G-308A TNF-alpha polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study.
Akkiz H; Bayram S; Bekar A; Ozdil B; Akgöllü E; Sümbül AT; Demiryürek H; Doran F
Cancer Epidemiol; 2009 Oct; 33(3-4):261-4. PubMed ID: 19683483
[TBL] [Abstract][Full Text] [Related]
14. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
[TBL] [Abstract][Full Text] [Related]
15. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk.
Liarmakopoulos E; Theodoropoulos G; Vaiopoulou A; Rizos S; Aravantinos G; Kouraklis G; Nikiteas N; Gazouli M
Mol Med Rep; 2013 Mar; 7(3):887-92. PubMed ID: 23258739
[TBL] [Abstract][Full Text] [Related]
16. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma.
Weng CJ; Hsieh YH; Tsai CM; Chu YH; Ueng KC; Liu YF; Yeh YH; Su SC; Chen YC; Chen MK; Yang SF
Ann Surg Oncol; 2010 Jul; 17(7):1808-15. PubMed ID: 20119675
[TBL] [Abstract][Full Text] [Related]
17. The contribution of caveolin-1 genotype and phenotype to hepatocellular carcinoma.
Hsu CM; Yang MD; Tsai CW; Ho CY; Chang WS; Chang SC; Jeng LB; Tsai Y; Tsai FJ; Bau DT
Anticancer Res; 2013 Feb; 33(2):671-7. PubMed ID: 23393366
[TBL] [Abstract][Full Text] [Related]
18. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
[TBL] [Abstract][Full Text] [Related]
19. Relationship between functional polymorphism in the Aurora A gene and susceptibility of hepatocellular carcinoma.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ozdil B
J Viral Hepat; 2010 Sep; 17(9):668-74. PubMed ID: 20002563
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ozdil B
Cancer Epidemiol; 2010 Jun; 34(3):298-302. PubMed ID: 20347627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
